Overview

MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
0
Participant gender:
All
Summary
1. To test for equivalence in terms of catch-up growth between the 2 therapeutic regimens 2. To specify the best period of treatment 3. To assess the efficacy of treatment based on final adult height of these children
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sanofi
Criteria
Inclusion Criteria:

- Pre-pubertal children of either sex presenting with severe early onset intrauterine
growth retardation (I.U.G.R.)

- Height Less Than or Equal to -3 SD

Exclusion Criteria:

- Age less than 3 years

The above information is not intended to contain all considerations relevant to a patient's
potential participation in a clinical trial.